2.4 mm Variable Angle LCP Two-Column Volar Distal Radius (VALCP2010)

A Prospective Multicenter Case-series of Patients Treated With the 2.4 mm Variable Angle LCP Two-Column Volar Distal Radius Plate ®

The purpose of this study is to is to evaluate the postoperative loss of reduction rate in patients with distal radius fractures treated using the 2.4 mm Variable Angle LCP Two-Column Volar Distal Radius Plate ®.

Study Overview

Status

Completed

Detailed Description

The treatment of choice for distal radius fractures is anatomic reduction with stable fixation. This is commonly achieved via open reduction and internal fixation with angle-stable designed locking plates using either a volar or dorsal approach. Frequent complications of tendinitis are associated with the latter approach. Palmar application of angle-stable plates reduces this problem of extensor tendon irritation; however a high incidence of fracture collapse has been documented. Currently, there are no existing locking plates that provide sufficient stability particularly for complex fractures. Insufficient fragment fixation can result in loss of reduction due to interfragmentary movement and lead to mal- or nonunion.

The Variable Angle LCP Two-Column Volar DR plate (VA LCP DR) is a novel development of the LCP Distal Radius Plate System, which is designed to treat a wide variety of distal radius fracture patterns. Because of its design (ie, low plate and screw profile, polished surface, rounded edges, various locking options), not only can the potential for tendon adhesions and soft tissue irritation be minimized, the plate can address fragments individually for each fracture type. Thus, the versatility of VA LCP facilitates the reduction and stabilization of even the most complex fractures, including those in osteoporotic bone.

This prospective case-series will evaluate the performance of the new VA LCP DR plate in the treatment of complex articular fractures of the distal radius. The primary objective of this study involves the documentation of postoperative loss of reduction; functional outcomes, quality of life and rate of complications associated with fracture fixation will also be assessed as part of the secondary study aims.

Study Type

Interventional

Enrollment (Actual)

74

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Graz, Austria, 8020
        • Unfallkrankenhaus Graz
      • Berlin, Germany
        • Charité Berlin
      • Münster, Germany, 48149
        • Universitätssklinikum Münster
      • Basel, Switzerland, 4056
        • Universitätsspital Basel
      • Luzern, Switzerland, 6000
        • Luzerner Kantonsspital
      • Zürich, Switzerland, 8008
        • Spital Zollikerberg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged ≥ 18 years
  • Patients with closed, partial or complete articular distal radius fractures classified as: AO 23 B3 and AO 23 C1, C2, C3 confirmed by CT scan
  • Definitive primary fracture treatment with a VA LCP DR
  • The patient is willing and able to participate in the study follow-up examinations according to the protocol
  • The patient is able to understand and read the local language at an elementary level
  • The patient or his/her legal guardian is willing and able to give his informed consent to participate in the study
  • Woman must be one of the following:
  • Postmenopausal defined as amenorrhea for at least 6 months before screening and a serum follicle stimulating hormone (FSH) level consistent with postmenopausal status
  • Surgically sterile, (have had a hysterectomy or bilateral oophorectomy, tubal ligation, or otherwise be incapable of pregnancy)
  • Abstinent (at the discretion of the investigator) or,
  • If sexually active, be practicing an effective method of birth control such as hormonal prescription oral contraceptives, progesterone implants or injections, intrauterine device (IUD), a double-barrier method such as condoms, diaphragms or cervical caps with spermicidal foam, cream or gel, or male partner with a vasectomy.
  • Women of childbearing potential must have a negative serum β-human chorionic gonadotropin (β-hCG) pregnancy test, or a negative urine pregnancy test at screening.

Exclusion Criteria:

  • Previous ipsilateral distal radius fracture
  • Other fractures of the ipsilateral side (except ulna)
  • Pathologic fracture due to malignancy
  • The patient suffers from a polytrauma
  • The patient is affected by drug or alcohol abuse
  • The patient suffers from active malignancy
  • Neurological and psychiatric disorders
  • The patient has participated in any other device or drug related clinical trial within the previous month
  • The patient is a prisoner
  • Breast feeding woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Variable Angle Distal Radius Plate
Fracture reduction with distal radius plate
Other Names:
  • 2.4 Variable Angle LCP Two-Column Volar Distal Radius Plate®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loss of reduction
Time Frame: over 1 year

Loss of reduction will be defined as the change in measurement* determined to 0.5 mm or 1 degree of accuracy:

*Any change in angles, length or secondary fragment displacement (ie, radial height (length), radial inclination, ulnar variance, gap, step-off, palmar tilt (inclination) / dorsal tilt, scapholunate angle, teardrop angle, and the AP distance).

over 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of fracture fixation complications
Time Frame: Baseline
Baseline
Wrist function
Time Frame: 12 weeks
Bilateral Range of motion (ROM)
12 weeks
Grip strength
Time Frame: 12 weeks
With Jamar dynamometer
12 weeks
Wrist pain and disability in functional activities
Time Frame: Baseline
Patient self-assessment of wrist function questionnaire (PRWE)
Baseline
Quality of Life
Time Frame: Baseline
Health-related quality of life (EQ5D)
Baseline
Implantation and system feedback
Time Frame: Baseline
Baseline
Rate of fracture fixation complications
Time Frame: 12 weeks
12 weeks
Rate of fracture fixation complications
Time Frame: 1 year
1 year
Wrist function
Time Frame: 1 year
Bilateral Range of motion (ROM)
1 year
Grip strength
Time Frame: 1 year
With Jamar dynamometer
1 year
Wrist pain and disability in functional activities
Time Frame: 12 weeks
Patient self-assessment of wrist function questionnaire (PRWE)
12 weeks
Wrist pain and disability in functional activities
Time Frame: 1 year
Patient self-assessment of wrist function questionnaire (PRWE)
1 year
Quality of Life
Time Frame: 12 weeks
Health-related quality of life (EQ5D)
12 weeks
Quality of Life
Time Frame: 1 year
Health-related quality of life (EQ5D)
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jesse B Jupiter, MD, Massachusetts General Hospital, Orthopaedic Surgery, Yawkey Center, Suite 2100, 55 Fruit Street, Boston, MA 02114, USA
  • Principal Investigator: Andreas Schierz, MD, Spital Zollikerberg, Unfallchirurgie, Trichtenhauserstrasse 20, CH-8125 Zollikerberg, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Actual)

February 1, 2014

Study Completion (Actual)

May 1, 2014

Study Registration Dates

First Submitted

March 25, 2010

First Submitted That Met QC Criteria

April 13, 2010

First Posted (Estimate)

April 14, 2010

Study Record Updates

Last Update Posted (Estimate)

September 19, 2014

Last Update Submitted That Met QC Criteria

September 18, 2014

Last Verified

September 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Distal Radius Fractures

Clinical Trials on Variable Angle Distal Radius Plate ® (Surgery)

3
Subscribe